These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 11374247

  • 1. Immunohistochemical study on proliferative activity of experimental cholesteatoma.
    Park K, Park HJ, Chun YM.
    Eur Arch Otorhinolaryngol; 2001 Mar; 258(3):101-5. PubMed ID: 11374247
    [Abstract] [Full Text] [Related]

  • 2. Reversibility of experimental cholesteatoma epithelium using Mongolian gerbils.
    Park K, Choung YH, Chun YM, Lee JS, Hong SP.
    Acta Otolaryngol; 2005 May; 125(5):540-6. PubMed ID: 16092548
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Enhanced epithelial proliferation due to elevated levels of interleukin-1 receptors in middle ear cholesteatomas.
    Bujia J, Kim C, Ostos-Aumente P, Lopez-Villarejo J, Kastenbauer E.
    Eur Arch Otorhinolaryngol; 1997 May; 254(1):6-8. PubMed ID: 9115708
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Immunohistochemical demonstration of c-myc oncogene product in middle ear cholesteatoma.
    Holly A, Sittinger M, Bujia J.
    Eur Arch Otorhinolaryngol; 1995 May; 252(6):366-9. PubMed ID: 8679157
    [Abstract] [Full Text] [Related]

  • 15. A study on epidermal proliferation ability in cholesteatoma.
    Tanaka Y, Shiwa M, Kojima H, Miyazaki H, Kamide Y, Moriyama H.
    Laryngoscope; 1998 Apr; 108(4 Pt 1):537-42. PubMed ID: 9546266
    [Abstract] [Full Text] [Related]

  • 16. [Immunohistochemical studies with middle ear mucosal remnants in cholesteatoma].
    Sudhoff H, Borkowski G, Bujia J, Hildmann H, Fisseler-Eckhoff A.
    HNO; 1997 Aug; 45(8):630-5. PubMed ID: 9378670
    [Abstract] [Full Text] [Related]

  • 17. [Epithelium-stroma interaction in cholesteatoma of the middle ear].
    Jacob R, Welkoborsky HJ, Mann W.
    Laryngorhinootologie; 2001 Jan; 80(1):11-7. PubMed ID: 11272241
    [Abstract] [Full Text] [Related]

  • 18. [Evaluation of epithelial proliferation and apoptosis in cholesteatoma of adults].
    Olszewska E, Chodynicki S, Chyczewski L.
    Otolaryngol Pol; 2003 Jan; 57(1):85-9. PubMed ID: 12741150
    [Abstract] [Full Text] [Related]

  • 19. Role of Bcl-xL protein in differentiation and apoptosis of human middle ear cholesteatoma epithelium.
    Kojima H, Miyazaki H, Tanaka Y, Shiwa M, Koga T, Moriyama H.
    Arch Otolaryngol Head Neck Surg; 1999 Jul; 125(7):738-42. PubMed ID: 10406309
    [Abstract] [Full Text] [Related]

  • 20. Some markers of proliferative activity in cholesteatoma epithelium in adults.
    Olszewska E, Chodynicki S, Chyczewski L, Rogowski M.
    Med Sci Monit; 2006 Aug; 12(8):CR337-40. PubMed ID: 16865065
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.